Travere Therapeutics, Inc. Quarterly Amortization of Intangible Assets in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Travere Therapeutics, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2012 to Q3 2024.
  • Travere Therapeutics, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $10.8M, a 0.88% decline year-over-year.
  • Travere Therapeutics, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $39M, a 45.7% increase year-over-year.
  • Travere Therapeutics, Inc. annual Amortization of Intangible Assets for 2023 was $36.3M, a 95% increase from 2022.
  • Travere Therapeutics, Inc. annual Amortization of Intangible Assets for 2022 was $18.6M, a 68.4% increase from 2021.
  • Travere Therapeutics, Inc. annual Amortization of Intangible Assets for 2021 was $11M, a 50.8% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $39M $10.8M -$96K -0.88% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $39.1M $9.9M -$490K -4.72% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $39.6M $9.35M +$3.29M +54.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $36.3M $8.93M +$9.53M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $26.8M $10.9M +$5.83M +115% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $20.9M $10.4M +$2.82M +37.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $18.1M $6.06M -$494K -7.54% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $18.6M -$603K +$6.78M +91.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $11.8M $5.08M -$1.27M -19.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $13.1M $7.57M +$1.44M +23.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $11.7M $6.56M +$604K +10.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $11M -$7.39M -$13.3M -224% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $24.4M $6.34M +$321K +5.33% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $24.1M $6.14M +$851K +16.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $23.2M $5.95M +$778K +15% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $22.4M $5.96M +$842K +16.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $21.6M $6.02M +$1.02M +20.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $20.6M $5.29M +$429K +8.83% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $20.2M $5.17M +$443K +9.36% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $19.7M $5.11M +$404K +8.58% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $19.3M $5.01M +$382K +8.26% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $18.9M $4.86M +$361K +8.03% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $18.6M $4.73M +$532K +12.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $18M $4.71M +$374K +8.63% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $17.7M $4.63M +$119K +2.64% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $17.5M $4.5M +$176K +4.08% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $17.4M $4.2M +$28K +0.67% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $17.3M $4.34M +$206K +4.99% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $17.1M $4.51M +$437K +10.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $16.7M $4.32M +$409K +10.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $16.3M $4.17M +$286K +7.36% Jan 1, 2017 Mar 31, 2017 10-Q/A 2018-07-06
Q4 2016 $16M $4.13M +$315K +8.26% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $15.7M $4.07M +$194K +5.01% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $15.5M $3.91M +$103K +2.71% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $15.4M $3.89M +$2.15M +124% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $13.2M $3.81M +$2M +111% Oct 1, 2015 Dec 31, 2015 10-K/A 2018-07-06
Q3 2015 $11.2M $3.88M +$2.06M +113% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $9.17M $3.81M +$2.27M +148% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $6.9M $1.74M +$1.62M +1422% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $5.28M $1.81M +$1.59M +714% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $3.69M $1.82M +$1.76M +3454% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $1.93M $1.54M +$1.49M +2945% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $438K $114K +$114K Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $324K $222K Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 $51.1K +$16.2K +46.4% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-13
Q2 2013 $50.5K +$13.9K +38.1% Apr 1, 2013 Jun 30, 2013 10-Q 2013-09-16
Q1 2013 $0 $0 Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q3 2012 $34.9K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 $36.6K Apr 1, 2012 Jun 30, 2012 10-Q 2013-09-16
Q1 2012 $0 Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-09-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.